|
?:abstract
|
-
Objectives: To clarify the clinical characteristics of cured patients with coronavirus disease (COVID-19), and to clarify the re-infection and person-to-person transmission in the cured Methods: A total of 187 cured COVID-19 patients with antibody test were followed up every 2 weeks in this retrospective observational study Assessment for general condition, symptoms, epidemiological contact history, polymerase chain reaction (PCR) assay, and antibody tests were performed and recorded Information from Guangzhou CDC was also screened Results: There were 33 (17 6%) patients with negative results for IgG and 35 (18 7%) patients with positive results for IgM The average days of antibody detection from disease onset were 53 0 PCR assay was positive in 10 (5 3%) patients during the follow-up Neither IgG nor IgM results showed a relationship with PCR test results (all P > 0 05) Neither re-infection nor person-to-person transmission was found in the cured patients Factors associated with appearance of antibody comprised hospitalization days (OR: 1 06, 95%CI: 1 02-1 11, P = 0 006) and antibiotics treatment (OR: 3 50, 95%CI: 1 40-8 77, P = 0 007) Conclusions: In our study, no evidence of person-to-person transmission was found in cured COVID-19 patients There seemed to be no re-infection in the cured COVID-19 patients in Guangzhou These finding suggest that the cured do not cause the spread of disease Additionally, neither IgG nor IgM can be used to replace the PCR test in cured patients
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}